 Sex differences have been observed in adverse drug reactions, ADRs. Psychotropic, cardiovascular, and analgesic medications have all been studied for their potential sex bias in ADRs. Lithium was found to cause more thyroid dysfunction in women, while amosulpride-induced prolactin increase was more pronounced in women than in men. Serious ADRs such as clozapine-induced neutropenia, and simvastatin-slash-adervastatin-related abnormal liver function tests were more common in men. These findings suggest that sex should be considered when prescribing certain medications, as some may pose greater risks to women than men. This article was authored by Yuting Shaan, Li Cheng, Yuqi Zhou, and others.